Sowell Financial Services LLC bought a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 92,563 shares of the company's stock, valued at approximately $1,977,000. Sowell Financial Services LLC owned approximately 0.23% of Phibro Animal Health as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Axecap Investments LLC purchased a new position in shares of Phibro Animal Health in the 1st quarter worth approximately $3,696,000. Harbor Capital Advisors Inc. grew its holdings in Phibro Animal Health by 4,727.2% during the first quarter. Harbor Capital Advisors Inc. now owns 10,813 shares of the company's stock valued at $231,000 after purchasing an additional 10,589 shares during the period. Curat Global LLC bought a new position in shares of Phibro Animal Health during the 1st quarter worth $146,000. Summit Global Investments grew its stake in shares of Phibro Animal Health by 39.8% during the 1st quarter. Summit Global Investments now owns 37,989 shares of the company's stock worth $811,000 after acquiring an additional 10,808 shares during the period. Finally, GAMMA Investing LLC increased its stake in shares of Phibro Animal Health by 2,011.4% in the first quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock worth $784,000 after purchasing an additional 34,979 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.
Phibro Animal Health Trading Down 2.0%
Phibro Animal Health stock traded down $0.49 during trading hours on Wednesday, reaching $23.96. The company had a trading volume of 215,002 shares, compared to its average volume of 206,592. The company has a 50-day moving average price of $21.49 and a 200 day moving average price of $21.91. Phibro Animal Health Corporation has a 12-month low of $16.16 and a 12-month high of $26.55. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The firm has a market cap of $971.10 million, a price-to-earnings ratio of 30.72, a P/E/G ratio of 0.47 and a beta of 0.74.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Equities analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.
Phibro Animal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.00%. Phibro Animal Health's dividend payout ratio is currently 61.54%.
Wall Street Analyst Weigh In
Several research firms have issued reports on PAHC. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a research report on Monday. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research note on Monday. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $20.80.
Check Out Our Latest Analysis on Phibro Animal Health
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
